Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ephedrine Pretreatment with Low-Dose Rocuronium for RSII
NCT05725031Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Apr 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ephedrine, sponsored by Ain Shams University. Started Apr 2023; status: completed.
02
Drugs
ephedrine
Beyond the preview
Go deeper on NCT05725031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05725031.